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Abstract. In cats, the low blood volume, along with other morpho-physiological features, 
restraints the possibility of serial blood sampling, and the procedure itself is an important stress factor.  
The present study aimed to evaluate the health status of a group of cats, based on the analysis of the 
metabolic profile evolution, during a bioequivalence study, as well as the influence exerted by the 
serial blood sampling over the blood parameters. The investigations were carried out on a group of 37 
adult cats (15 females and 22 males), European race, with bodyweights ranging from 2 - 4 kg. The 
protocol had two stages, with an interval of 14 days in-between them. A number of 11 blood samples 
were collected during each phase. According to the protocol, the biochemical tests were associated 
with hematological and clinical tests in the initial and final stages of the experiment. The evolution of 
the metabolic profiles parameters indicated non-significant variations, with individual values in-
between the physiological ranges. Regarding the hematological parameters, the values were situated 
in-between the normal physiological ranges. Due to the variables that can influences the result of the 
serial blood sampling in a bioequivalence testing, a metabolic profile it is needed in order to evaluate 
the general health status and the stress response. The comparative analysis of the biochemical and 
hematological parameters revealed small variations, with no pathological consequence on the general 
health status, indicating a good accommodation to the stress induced by the serial blood sampling. 
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INTRODUCTION 
 
Assessment of the metabolic profile requires testing a large number of blood 
parameters to define the health of the animal in one or several organs (liver, kidney, exocrine 
pancreas and endocrine glands). According to other authors (Ettinger, 1995, Payne, 1972) 
there is also a strong relationship between the animal welfare and the blood biochemical 
parameters tested. Investigating the metabolic profile is a key step in the bioequivalence 
studies, consisting in the comparison of two drug formulations, containing the same active 
substance, in order to asses the possibility of using alternatively or replace them.  
Bioequivalence shows that when two drug formulas (test and reference) have similar 
concetation-time profiles in the blood and plasma, their therapeutic effects are identical 
(Altintas and Yarsan, 2009). For bioequivalence studies, is absolutely necessary to determine 
the metabolic profile of the animals used for the investigation, because it shows the general 
health status and their adjustment to the testing conditions and to te tested substance, 
respectively. The evaluation of the metabolic profile must also be supplemented with a blood 
profile and a general clinical exam (Rebar, 1999).  
The present paper aims to analyse the evolution of the metabolic profile in order to 
asses the health status in a group of cats, during a bioequivalence test of an antihelmintic 
product, which implies collecting a large number of serial blood samples. 
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MATERIALS AND METHODS 
 
The research was carried out in the laboratory of the department of Physiology of the 
Faculty of Veterinary Medicine, Cluj-Napoca, in the period march-may 2012. The 
investigation of the metabolic profile parameters was carried out on a group of 37 adult cats 
(15 females and 22 males) European race, weighing between 2 – 4 kg, from the village areas. 
The animals were kept for 7 days to the experimental conditions, being kept in individual 
cages, with fresh water and food ad libitum (dry and canned food).  
During this period, the laboratory and clinical exams were performed, according to the 
inclusion and exclusion criteria in the experiment. The maximum amount of blood that can be 
collected from a cat was established, based on the weight ratio method. Thus, it was established 
that from a cat it can be collected safely 13 ml of blood/kg. The cats from the experimental 
group had a weight ranging between 2-2.5 kg, consequently from each cat was collected 2 – 2.5 
ml of blood/sample. The testing protocol included two stages, with an interval of 14 days in-
between them. During each stage, 11 blood samples were collected, at increasing time intervals 
(0-24h). The biochemical tests were associated with hematological and clinical evaluations.  
The blood samples were collected in vacutubes with EDTA for the hematological tests 
and Li-Heparin for the biochemical parameters. The hematological exams were performed 
using the automatic analyzer Abacus Junior Vet and associated with blood smears for the 
leucocitary formula. The biochemical tests were performed with the help of the automatic 
analyzer for biochemistry VetScan, using Comprehensive Diagnostic Profile kits. Using these 
kits, the following parameters were determined: ALB (albumin), ALP (alkalin phospatase), 
ALT (Alanine transaminase), AMY (amylase), BUN (blood urea nitrogen), CRE (creatinine), 
GLOB (globulins), GLU (glucose), K
+
 (potassium), NA
+ 
(sodium) and TP (total serum protein). 
 
 
RESULTS AND DISCUSSIONS 
 
Bioequivalence testing is based on the comparative evaluation of the bioavailability of 
two or more drug formulas of the same active ingredient, administered the same way, 
comparing the rate and degree of absorption of the different drug formulas (Madisson, 2008).  
The systemic availability is determined by the absorption rate of the active substance, 
being influenced by the nature of the active substance, dosage form and their interaction with 
the absorption media, by systemic availability being measured the proportion of active 
molecules available to exert their action (Allain, 1996; Mycek et al., 1997; Stroescu, 19997, 
Mungiu, 1995). It is considered that the bioequivalence of a drug is achieved when the 
proportion and rate of absorption do not differ compared to those of the reference product, 
administered in the same molar dose (Altintas şi Yarsan, 2009, Posyniak et al., 2001, Sumano et 
al., 2001, Martinez et al., 2001). Concerning the hematological values obtained, it was observed 
that the total number of erythrocytes was constant, while the values from the hematocrit and 
hemoglobin, obtained after the first stage of blood sampling, presented a slight drop in values, 
though with no major statistical significance. The erythrocyte indices, calculated based on the 
three major erythrocyte values, remained constant during the two phases of the blood sampling. 
Analyzing the leukocitary population, it was identified a physiological monocitosis, 
caused mainly by the stressing factors, and sustained by the modifications in the 
biochemical profile, observed after the first blood sampling. In the second phase of the 
testing protocol, the values recorded in the case of the hematological exam were constant, 
due to the adaptation of the animals to the experimental conditions. 
3 
 
Tabel 1 
 
The evolution of hematologic parameters during sampling 
 
Issue 
Phase I Phase II Reference 
values 
T0 T48 T0 T48 
Ht (%) 35,86 ± 4,79 30,32 ± 3,59 36,18 ± 5,49 38,33 ± 6.81 24,0-45,0 
MCV (fl) 40,95 ± 5,63 45.86 ± 5.78 44.82 ± 7.66 44.50 ± 5.13 39-55 
MCH (pg) 14.80 ± 1.41 15.27 ± 0.99 15.17 ± 2.02 14.92 ± 1.48 12.5-17.5 
MCHC (g/dl) 34.80 ± 2.65 33.69 ± 2.72 33.60 ± 2.77 33.93 ± 1.97 30.0-36.0 
WBC (g/l) 13.14 ± 3.69 13.18 ± 4.81 13.10 ± 4.14 12.00 ± 3.20 6.00-17.00 
NEUTROPHILLS 
(%) 
62.82 ± 12.78 65.41 ± 8.94 60.36 ± 10.06 61.98 ± 10.06 60.00-77.00 
EOZINOPHILLS 
(%) 
4.95 ± 2.85 4.00 ± 1.8 5.64 ± 4.30 3.86 ± 1.28 2.00-10.00 
LIMPHOCITE (%) 19.59 ± 2.87 19.82 ± 4.16 25.36 ± 10.33 24.82 ± 8.15 12.00-30.00 
MONOCITE (%) 6.5 ± 2.48 6.95 ± 2.10 11.18 ± 4.48 6.18 ± 2.32 3.00-10.00 
BAZOFILE (%) 0.14 ± 0.35 0.23 ± 0.43 0.36 ± 0.49 0.41 ± 0.50 0-1.00 
 
The protein profile of blood helps to assess the general health status. Thus, the total 
proteins, albumins and globulin concentration were determined. Total proteins (TP) 
concentrations indicate the nutritional status of the animals. Their concentrations vary 
according to sex, physiological state, food regime, temperature, age, osmotic pressure, etc. 
normal values have been recorded both in the first phase and in the second one.  
These results are due to the fact that the cats were well fed and had water at their 
disposal. Albumins make up for 45% of the total proteins, playing an important role in the 
osmotic pressure regulation of the body fluids (Jha et al, 2007). The albumin concentration 
showed some small variation, but without any major statistical significance. 
 
 
Tabel 2 
 
The evolution of the protein profile and glucose concentration during sampling 
 
Issue 
Phase I Phase II Reference 
values T0 T48 T0 T48 
TP (g/l) 6,55 ± 0.89 6,33 ± 0.87 6,39 ± 0,87 6,17 ± 0,73 5,4 - 8,2 
Alb (g/dl) 3,21 ± 0.48 2,97 ± 0.48 3,21 ± 0,47 
3,12 ± 0,48 
 
2,2-4,4 
Glob (g/l) 2,98 ± 0.75 3,07 ± 0.64 2,97 ± 0,63 2,98 ± 0,46 1,5-5,7 
Glu (mmol/l) 
92,09 ± 
14.18 
140,67 ± 21.00 
98,64 ± 
18,93 
97,32 ±  19,05 70-150 
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Globulins are a big family of globular proteins with a high molecular weight and a 
higher solubility than that of albumins. Some globulins are produced in the liver as others are 
produced by the immune system. The serum concentration of globulins drops in liver diseases, 
but the decrease is not so important like that of the albumins (Thrall, 2012).  
The albumins:globulins ratio remained constant throughout the sampling period, 
without any major variations or changes, due to the fact that the cats quickly adapted to 
the experimental conditions. Blood glucose concentration is a very relevant indicator for 
determining the response of an organism under the action of some potentially stressing 
factors (Capes et al., 2001). The glucose level increased significantly 48 after the first 
sampling, the values still remaining within the normal rages. This change can be 
associated with the stress induced by the serial sampling. 
 
Tabel 3 
 
The evolution of the liver and pancreas enzymes during sampling 
 
Issue 
Phase I Phase II Reference 
values 
T0 T48 T0 T48 
AST (U/l) 36,05 ± 5,12 34,88 ± 6,66 36,09 ± 5,90 35,45 ± 6,21 8,9-49 
ALT (U/l) 63,73 ± 18.50 61,05 ± 16.14 
63, 50 ± 
18,17 
61,33 ± 15,75 20-100 
AMY (U/l) 
696,91  
± 315.58 
594,91] 
±101.23 
692,80 
±307,24 
594,91 ± 
104,23 
300-1100 
ALP (U/l) 53,09 ± 16.69 59,23 ± 15.23 54,07± 16,15 55,04 ± 15,12 10-90 
 
 
In order to evaluate the liver and pancreas functions, the main enzymes were 
determined, that characterize the status of these two organs: amylase, alanine aminotransferase 
(ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) respectively.  
Alanine aminotransferase (ALT) is an enzyme found mostly in liver, being a good 
indicator of a hepatic dysfunction (Thrall, 2012). Minor variations were recorded during the 
sampling period, but with no statistical significance. Aspartate aminotransferase (AST) is a 
liver and muscle enzyme that plays an important role in amino acid metabolism. It is not an 
indicator of liver problems but major variations indicate biliary obstructions, within or 
outside if the liver (Rebar, 2008 A). The values recorded in the experiment were well within 
the normal values. Alkaline phosphatase (ALP), a mostly hepatic enzyme, is found in small 
quantities in cats compared to dogs and it is sensitive to changes to the biliary ducts.  
More authors state that any rise above the normal values is a sign of a liver disease 
(Ettinger, 1999, Rebar et al., 1999). The cats take in this study did not show any major 
variations throughout the testing period. Amylase (AMY) is a pancreatic enzyme catalyzing 
the hydrolysis reactions of oligo- and polysaccharides. In the case of a pancreatic lesion, the 
concentration of this enzyme increases as a fast response. The concentration of this enzyme 
did not suffer any changes, indicating that the cats did not have any pancreatic lesions. 
Small variations were recorded in the first 48 hours after sampling, caused by the stress 
induced by environment change and serial sampling. 
In order to assess the kidney function, blood urea nitrogen (BUN) and creatinine were 
determined.Urea nitrogen is the final product of protein metabolism, being eliminated through 
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the kidneys; it is an indicator of the kidney health status. The values recorded for the BUN 
were constant, without any major variations throughout the two sampling phases. 
 
Tabel 4 
 
The evolution of the renal indicators and the main electrolytes during sampling 
 
Issue Phase I Phase II 
Reference 
values 
T0 T48 T0 T48 
CRE 
(µmol/l) 
1,04 ± 0,46 1,03 ± 0,52 1,06 ± 053 1,17 ± 0,55 0,3 - 2,1 
BUN 
(mmol/l) 
18,36 ± 3,68 17,52 ± 3,22 
19,09 ± 
3,34 
17,34 ± 4,25 8,8-26 
NA 
(mmol/l) 
148,95 ± 9,41 142,59 ± 5,26 
149,27 ± 
8,58 
144,95 ± 
7,93 
142-164 
K 
(mmol/l) 
4,64 ± 0,63 4,50 ± 0,70 4,37 ±0,60 4,43 ± 0,61 3,7-5,8 
 
Creatinine is a byproduct from the muscle metabolism, being completely excreted by 
glomerular filtration (Rebar, 2008 A). Creatinine levels maintained within the physiological 
ranges,small variation occurring in the first sampling phase. 
Sodium and potassium (Na and K) are the main electrolytes in the animal body, 
playing an important role in the blood volume, blood pressure regulation, osmotic equilibrium 
and pH. The values recorded were situated within the normal ranges. There results, correlated 
with the hematocrit values and the results from the clinical test, indicate that the cats had a 
proper blood volume throughout the experimental period.  
 
CONCLUSIONS 
 
The metabolic profile reveals the health status of the animals, being a central point of 
the bioequivalence tests. Together with the metabolic profile, it is necessary for e clinical test 
to be carried out in order to better assess the health status of the animals. 
In the case of serial blood sampling in cats, it is essential to maintain a constant blood 
volume, throughout the testing period. The dehydration degree was checked both via clinical 
exam and via laboratory analysis. From a hematological point of view, small variations were 
recorded during the sampling period, both in erythrocyte and leukocyte populations. These 
variations were caused by the stress and adaptation of the animals. 
The values recoded in the hematological analysis were correlated with the electrolytes 
concentrations (sodium and potassium), their values situating in the normal ranges.  It can be 
concluded that due to the permanent access to water and food, the animals maintained their 
blood volume throughout the sampling period. 
The analysis of the protein profile revealed a drop in the total protein concentrations 
after the first sampling, the values returning to their initial levels after 48 hours. The albumin 
and globulin concentrations were constant throughout the sampling period. 
Blood glucose concentration rose considerably after the initial sampling sessions, 
phenomenon that can be attributed to the stress caused by manipulation and sampling process. 
The cats did not show any liver or pancreas damage, to this end, the main parameters 
being evaluated. These parameters were constant throughout the sampling period, with small 
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variations of the liver enzymes (ALT and AST) after the first sampling. The concentrations of 
these 2 enzymes slightly decreased due to stress and adapting mechanisms to the new 
conditions. Regarding the pancreatic parameters, the values recorded were in the normal 
ranges, indicating that the cats did not suffer from any pancreatic lesions. 
The urinary test completed the metabolic profile by determining the urea nitrogen and 
creatinine. The determinations indicate the glomerular filtration capacity.  
The results recorded were in-between the physiological limits, indicating that the cats 
did not suffer from any renal disease. 
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